Literature DB >> 3685977

Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma.

E Cesarman1, R Dalla-Favera, D Bentley, M Groudine.   

Abstract

The c-myc proto-oncogene is involved in chromosomal translocations that are specifically and consistently found in Burkitt lymphoma. Although these translocations are thought to lead to a deregulation of c-myc expression, the structural and functional basis of this phenomenon has not been identified. Mutations in a specific region spanning approximately 70 base pairs and located at the 3' border of the first exon of translocated c-myc alleles were consistently detected in Burkitt lymphoma cells carrying classic (8:14) as well as variant (8:22 and 2:8) translocations. These structural alterations were accompanied by an altered pattern of c-myc transcription, namely, the removal of a block to transcriptional elongation that has been mapped to the same region. Thus, specific c-myc mutations leading to the alleviation of this block to transcriptional elongation may represent a general mechanism causing c-myc activation in Burkitt lymphoma.

Entities:  

Mesh:

Year:  1987        PMID: 3685977     DOI: 10.1126/science.3685977

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  51 in total

1.  A cis-acting element in the promoter region of the murine c-myc gene is necessary for transcriptional block.

Authors:  H Miller; C Asselin; D Dufort; J Q Yang; K Gupta; K B Marcu; A Nepveu
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

Review 2.  Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients.

Authors:  Ethel Cesarman
Journal:  Cancer Lett       Date:  2011-04-13       Impact factor: 8.679

3.  Dysregulated TCL1 requires the germinal center and genome instability for mature B-cell transformation.

Authors:  Rhine R Shen; David O Ferguson; Mathilde Renard; Katrina K Hoyer; Unkyu Kim; Xingpei Hao; Frederick W Alt; Robert G Roeder; Herbert C Morse; Michael A Teitell
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

4.  Activation of the c-ski oncogene by overexpression.

Authors:  C Colmenares; P Sutrave; S H Hughes; E Stavnezer
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  A 5'-truncated c-myc gene variant not associated with a risk of cancer.

Authors:  N S Pellegata; G Bergamaschi; D Amadori; A Aloia; P Ballarini; L Del Senno; L Amaducci; G N Ranzani
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

6.  Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.

Authors:  T Albert; J Mautner; J O Funk; K Hörtnagel; A Pullner; D Eick
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

7.  c-myc overexpression is a tumor-specific phenomenon in a subset of human colorectal carcinomas.

Authors:  A Viel; R Maestro; G Toffoli; G Grion; M Boiocchi
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

8.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

9.  Regulation of 4F2 heavy-chain gene expression during normal human T-cell activation can be mediated by multiple distinct molecular mechanisms.

Authors:  T Lindsten; C H June; C B Thompson; J M Leiden
Journal:  Mol Cell Biol       Date:  1988-09       Impact factor: 4.272

10.  NF-kappa B sites function as positive regulators of expression of the translocated c-myc allele in Burkitt's lymphoma.

Authors:  L Ji; M Arcinas; L M Boxer
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.